Radically resected stage III colorectal cancer: sidedness and prognosis

被引：0
|
作者：
Massucci, M. [1 ,2 ]
Francesca, A. [3 ]
Veronica, M. [3 ]
Palloni, A. [3 ]
Frega, G. [3 ]
Ferracin, M. [4 ]
Porcellini, E. [4 ]
Brandi, G. [3 ]
Biasco, G. [3 ]
Garajova, I. [3 ]
机构：
[1] Osped St Orsola Malpighi, Bologna, Italy
[2] Osped St Orsola Malpighi, Bologna, Italy
[3] Univ Bologna, Univ Bolognat Orsola Malpighi Hosp, St Orsola Malpighi, Bologna, Italy
[4] Univ Bologna, Bologna, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A26
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic Impact of Primary Tumor Sidedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort
    Protasio, Bruno Medonca
    Castria, Tiago Biachi de
    Natalino, Renato
    Mangone, Flavia R.
    Saragiotto, Daniel Fernandes
    Sabbaga, Jorge
    Hoff, Paulo M.
    Chammas, Roger
    CLINICAL COLORECTAL CANCER, 2024, 23 (01) : 73 - 84
  • [42] Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma
    Sellner, FJ
    Riegler, FM
    Machacek, E
    EUROPEAN JOURNAL OF SURGERY, 1999, 165 (09) : 865 - 870
  • [43] Association of intratumoral FOXP3-positive regulatory T cells (Tregs) with adverse prognosis in radically resected (R0), stage II-III gastric cancer (GC)
    Graziano, F.
    Ruffini, P. A.
    Perrone, G.
    Catalano, V.
    Spino, C.
    Spoto, C.
    Santini, D.
    Muretto, P.
    Zingaretti, C.
    Tonini, G.
    Rabitti, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
    Graziano, Francesco
    Galluccio, Nadia
    Lorenzini, Paola
    Ruzzo, Annamaria
    Canestrari, Emanuele
    D'Emidio, Silvia
    Catalano, Vincenzo
    Sisti, Valerio
    Ligorio, Claudia
    Andreoni, Francesca
    Rulli, Eliana
    Di Oto, Enrico
    Fiorentini, Giammaria
    Zingaretti, Costantino
    De Nictolis, Michele
    Cappuzzo, Federico
    Magnani, Mauro
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (36) : 4789 - 4795
  • [45] POST-OPERATIVE XELOX AND CHEMORADIATION IN STAGE III-IV RADICALLY RESECTED GASTRIC CANCER PATIENTS: PRELIMINARY RESULTS OF A PILOT STUDY
    Orditura, Michele
    Martinelli, Erika
    Morgillo, Floriana
    Cecere, Sabrina
    Romano, Anna
    Murino, Paola
    Ravo, Enzo
    Galizia, Gennaro
    Renda, Andrea
    Conzo, Giovanni
    De Vita, Ferdinando
    Ciardiello, Fortunato
    ANNALS OF ONCOLOGY, 2011, 22 : v52 - v53
  • [46] MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer
    Matsuyama, Takatoshi
    Ishikawa, Toshiaki
    Mogushi, Kaoru
    Yoshida, Tsuyoshi
    Iida, Satoru
    Uetake, Hiroyuki
    Mizushima, Hiroshi
    Tanaka, Hiroshi
    Sugihara, Kenichi
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (10) : 2292 - 2299
  • [47] A combined nutritional risk index and carcinoembryonic antigen score predicts the outcome in radically resected colorectal cancer
    Chen, Guanzhou
    Xie, Jiang
    Li, Panhua
    Wang, Qin
    Ye, Qianwen
    Feng, Shouhan
    ANZ JOURNAL OF SURGERY, 2024, 94 (10) : 1818 - 1822
  • [48] Targeted treatment for resected stage II and III rectal cancer
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (06) : 567 - 567
  • [49] The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy
    Sunaga, T.
    Suzuki, S.
    Kogo, M.
    Kurihara, T.
    Kaji, S.
    Koike, N.
    Harada, N.
    Suzuki, M.
    Kiuchi, Y.
    EUROPEAN JOURNAL OF CANCER CARE, 2014, 23 (03) : 394 - 400
  • [50] Loss of YY1 expression predicts unfavorable prognosis in stage III colorectal cancer
    Kim, Hyunsung
    Bang, Seongsik
    Jee, Seungyun
    Park, Seongeon
    Kim, Yeseul
    Park, Hosub
    Jang, Kiseok
    Paik, Seung Sam
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (05) : 78 - 84
12345